Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The small hydrophobic (SH) protein is a viral protein encoded by the human respiratory syncytial virus (RSV), specifically in subgroup A strains. It consists of 64 amino acids and functions as a pH-dependent ion channel (viroporin). The SH protein inhibits apoptosis, modulates host cell secretory pathways, and can inhibit tumor necrosis factor alpha (TNF‐α) signaling. It is not essential for viral entry or syncytium formation but contributes to full virulence. Inhibitors like pyronin B block channel activity, suggesting a potential antiviral drug target.
Inhibition of ion channel activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Hydrophobic Protein of Respiratory Syncytial Virus A (SH).